Vote Scores
Filings read through

How funds voted at Joincare Pharmaceutical Group Industry Co., Ltd.

Filers reporting
16, year to 30 June 2026
Latest meeting on file
Meetings on file
13

In the year to 30 June 2026, 16 filers on Form N-PX reported votes at Joincare Pharmaceutical Group Industry Co., Ltd.. The votes fall in 2 meetings. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 94 marks to the ballot items, each with or against management. 84.0% of the marks are with management.

In the year to 30 June 2026, no say-on-pay item is on file for Joincare Pharmaceutical Group Industry Co., Ltd.. So there is no figure to give.

By filers reporting in the year to 30 June 2026, Joincare Pharmaceutical Group Industry Co., Ltd. was number 9,393 of 11,972 companies with a page and votes in that year. The number of filers reporting at Joincare Pharmaceutical Group Industry Co., Ltd. fell by 56.8% from the year to 30 June 2025 to the year to 30 June 2026. At the companies on this site with filers in both years, the total of filers reporting rose by 6.0%. In all seasons on file, category DIRECTOR ELECTIONS is 24.5% of the vote records at Joincare Pharmaceutical Group Industry Co., Ltd.. At all companies on this site, it is 52.2%.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 23 Sep 2024

20 filers reported votes at this meeting in the year to 30 June 2025. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    32 vote records from 4 filers. 0 of the 4 filers that marked the item voted against management.

    • Positions of 4 fund families
    • For 4
  2. Item 2: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    9 vote records from 5 filers. 0 of the 5 filers that marked the item voted against management.

    • Positions of 4 fund families
    • For 3
    • Split or no vote 1
  3. Item 3: Approve Authorization of Board to Handle All Related Matters

    23 vote records from 14 filers. 0 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 7
  4. Item 4: Approve Capital Source Used for the Share Repurchase

    23 vote records from 14 filers. 0 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 7
  5. Item 5: Approve Manner of Share Repurchase

    23 vote records from 14 filers. 0 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 7
  6. Item 6: Approve Period of the Share Repurchase

    23 vote records from 14 filers. 0 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 7
  7. Item 7: Approve Price Range and Pricing Principle of the Share Repurchase

    23 vote records from 14 filers. 0 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 7
  8. Item 8: Approve Purpose of Share Repurchase

    23 vote records from 14 filers. 0 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 7
  9. Item 9: Approve the Usage, Quantity, Proportion of the Company's Total Share Capital of the Repurchased Shares and...

    23 vote records from 14 filers. 0 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 7
  10. Item 10: Approve Transfer of Land Use Right and Its Ground Building and Related to the Transfer of Raised Funds...

    23 vote records from 14 filers. 14 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • Against 7
    • Against management 7
  11. Item 11: Approve Type of Share Repurchase

    23 vote records from 14 filers. 0 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 7

Positions of the fund families at the meeting of 23 Sep 2024

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

  • Proposal A: Approve Authorization of Board to Handle All Related Matters
  • Proposal B: Approve Capital Source Used for the Share Repurchase
  • Proposal C: Approve Manner of Share Repurchase
  • Proposal D: Approve Period of the Share Repurchase
  • Proposal E: Approve Price Range and Pricing Principle of the Share Repurchase
  • Proposal F: Approve Purpose of Share Repurchase
  • Proposal G: Approve the Usage, Quantity, Proportion of the Company's Total Share Capital of the Repurchased Shares and...
  • Proposal H: Approve Transfer of Land Use Right and Its Ground Building and Related to the Transfer of Raised Funds...

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Joincare Pharmaceutical Group Industry Co., Ltd., meeting of 23 Sep 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familyProposal AProposal BProposal CProposal DProposal EProposal FProposal GProposal H
BNY MellonForForForForForForForAgainst, against management
DimensionalForForForForForForForAgainst, against management
Franklin TempletonForForForForForForForAgainst, against management
Northern Trust and FlexSharesForForForForForForForAgainst, against management
State Street and SPDRForForForForForForForAgainst, against management
VanguardForForForForForForForAgainst, against management
WisdomTreeForForForForForForForAgainst, against management

Every meeting on file

Meetings of Joincare Pharmaceutical Group Industry Co., Ltd., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 2026135not reported
year to 30 June 2026162not reported
year to 30 June 2025163not reported
year to 30 June 2025171not reported
year to 30 June 2025181not reported
year to 30 June 20252011not reported
year to 30 June 2025356not reported
year to 30 June 2024324not reported
year to 30 June 2024353not reported
year to 30 June 2024341not reported
year to 30 June 2024351not reported
year to 30 June 2024362not reported
year to 30 June 2024361not reported

Say-on-pay, season by season

Say-on-pay at Joincare Pharmaceutical Group Industry Co., Ltd.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 202616not reportednot reported
year to 30 June 202537not reportednot reported
year to 30 June 202439not reportednot reported
Joincare Pharmaceutical Group Industry Co., Ltd. and the median of companies on this site, year to 30 June 2026
Say-on-payThis companyMedian of companies on this site
Filers against managementnot reported6.6%
Reported shares against managementnot reported2.9%

The median covers 3,799 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at Joincare Pharmaceutical Group Industry Co., Ltd. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS61424.5%
AUDIT-RELATED2449.7%
EXTRAORDINARY TRANSACTIONS391.6%
CAPITAL STRUCTURE62925.1%
COMPENSATION1425.7%
CORPORATE GOVERNANCE80432.1%
OTHER361.4%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. How funds voted at Joincare Pharmaceutical Group Industry Co., Ltd.. https://votescores.com/company/joincare-pharmaceutical-group-industry-co-ltd/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of Joincare Pharmaceutical Group Industry Co., Ltd. are on file?
13 meetings are on file, from 15 Sep 2023 to 1 Jun 2026. 8 meetings have 20 or more reporting filers and have their own page.
Did filers report proposals from security holders at Joincare Pharmaceutical Group Industry Co., Ltd.?
Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2026. The ballot shows the items that filers did report.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Joincare Pharmaceutical Group Industry Co., Ltd. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Joincare Pharmaceutical Group Industry Co., Ltd., grouped by company. The name is the most common spelling among filers. The filers wrote the filings. Filings read through .